Search Within

Philip Wayne Kantoff

Formats
  1. Journal Article (118)
  2. Meeting Abstract (71)
  3. Review (4)
  4. Correspondence (2)
  5. Editorial (2)
  6. Research Letter (1)
Groups
  1. Department of Medicine (198)
  2. Genitourinary Oncology Service (198)
  3. Solid Tumor Oncology Division (198)
  4. Sloan Kettering Institute Postdocs (71)
  5. GSK Faculty (26)
  6. Human Oncology and Pathogenesis Program (23)

More Groups

People
  1. Konrad Stopsack (44)
  2. Goutam Chakraborty (29)
  3. Ying Mazzu (29)
  4. Subhiksha Nandakumar (27)
  5. Michael Morris (26)
  6. Yuki Yoshikawa (23)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (14)
  5. 2021 (19)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (17)
  3. Cancer Research (16)
  4. Cancer (9)
  5. Cancer Epidemiology Biomarkers and Prevention (8)
  6. European Urology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (62)
  2. American Association for Cancer Research (46)
  3. Nature Publishing Group (16)
  4. Oxford University Press (11)
  5. Wiley Blackwell (11)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (198)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination treatment of PARP and SRC inhibitors in BRCA2 mutated prostate cancer
    Meeting Abstract

    Khan, N.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Atiq, M.; Yoshikawa, Y.; Lee, G. S. M.; Kantoff, P.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Mechanisms of resistance to poly (ADP-ribose) polymerase inhibitors in prostate cancer
    Meeting Abstract

    Atiq, M.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Aneuploidy drives lethal progression in prostate cancer
    Meeting Abstract

    Stopsack, K. H.; Whittaker, C. A.; Gerke, T. A.; Loda, M.; Kantoff, P. W.; Mucci, L. A.; Amon, A.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Hypermethylation of miR193b reactivates master drivers of the poor prognosis prostate cancer
    Meeting Abstract

    Mazzu, Y. Z.; Yoshikawa, Y.; Nandakumar, S.; Armenia, J.; Jehane, L.; Lee, G. S.; Chakraborty, G.; Kantoff, P.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A comparative analysis of fraction genome altered vs tumor mutational count in prostate cancer
    Meeting Abstract

    Chakraborty, G.; Atiq, M.; Nandakumar, S.; Mazzu, Y. Z.; Armenia, J.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Mucci, L.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program
    Journal Article

    Labbé, D. P.; Zadra, G.; Yang, M.; Reyes, J. M.; Lin, C. Y.; Cacciatore, S.; Ebot, E. M.; Creech, A. L.; Giunchi, F.; Fiorentino, M.; more...
    Nature Communications (2019)

    Fulltext@MSK | Save
  • Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer
    Journal Article

    Mazzu, Y. Z.; Yoshikawa, Y.; Nandakumar, S.; Chakraborty, G.; Armenia, J.; Jehane, L. E.; Lee, G. S. M.; Kantoff, P. W.
    Molecular Oncology (2019)

    Fulltext@MSK | Save
  • A novel mechanism driving poor-prognosis prostate cancer: Overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2)
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Coggins, S. A.; Nandakumar, S.; Gerke, T. A.; Pomerantz, M. M.; Qiu, X.; Zhao, H.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry
    Journal Article

    Francini, E.; Gray, K. P.; Shaw, G. K.; Evan, C. P.; Hamid, A. A.; Perry, C. E.; Kantoff, P. W.; Taplin, M. E.; Sweeney, C. J.
    Prostate Cancer and Prostatic Diseases (2019)

    Fulltext@MSK | Save
  • Novel RB1-loss transcriptomic signature is associated with poor clinical outcomes across cancer types
    Journal Article

    Chen, W. S.; Alshalalfa, M.; Zhao, S. G.; Liu, Y.; Mahal, B. A.; Quigley, D. A.; Wei, T.; Davicioni, E.; Rebbeck, T. R.; Kantoff, P. W.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save